Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(23)
Published: Dec. 1, 2024
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
lethal
cancers,
usually
diagnosed
at
an
advanced
stage.
Metabolic
reprogramming
plays
a
significant
role
in
HCC
progression,
probably
related
to
immune
evasion,
yet
key
gene
unclear.
In
this
study,
six
metabolism-related
genes
with
prognostic
implications
were
screened.
Correlation
analysis
between
and
cell
subtypes
was
conducted,
prominent
strongly
associated
immunosuppression,
SLC16A3,
identified.
Overexpression
SLC16A3
loss
T-cell
function
might
lead
upregulation
several
immunosuppressive
proteins.
Gene
enrichment
showed
correlated
primarily
involved
adhesion.
Single-cell
that
mainly
expressed
macrophages,
especially
some
tumour-promoting
macrophages.
Further
spatial
transcriptome
data
indicated
enriched
tumour
invasion
front.
The
mIHC
revealed
patients
high
expression
exhibited
significantly
reduced
infiltration
GZMB
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 23, 2025
Initially,
it
was
believed
that
glycolysis
and
DNA
damage
repair
(DDR)
were
two
distinct
biological
processes
independently
regulate
tumor
progression.
The
former
metabolic
reprogramming
rapidly
generates
energy
generous
intermediate
metabolites,
supporting
the
synthetic
metabolism
proliferation
of
cells.
While
DDR
plays
a
pivotal
role
in
preserving
genomic
stability,
thus
resisting
cellular
senescence
cell
death
under
both
physiological
radio-chemotherapy
conditions.
Recently,
an
increasing
number
studies
have
shown
closely
correlation
between
these
processes,
then
promoting
For
instance,
lactic
acid,
product
glycolysis,
maintains
acidic
microenvironment
not
only
fosters
invasion
but
also
facilitates
by
enhancing
AKT
activity.
Here,
we
provide
comprehensive
overview
enzymes
metabolites
involved
along
with
primary
methods
for
DDR.
Meanwhile,
this
review
explores
existing
knowledge
regulating
Moreover,
considering
significant
roles
development
resistance,
present
discusses
effective
direct
or
indirect
therapeutic
strategies
targeted
to
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 29, 2025
Abstract
SLC16A3,
belonging
to
the
SLC16
gene
family,
is
involved
in
transportation
of
monocarboxylate.
SLC16A
family
members
play
important
roles
tumorigenesis,
nonetheless,
specific
involvement
SLC16A3
tumor
prognosis
and
diagnosis
human
cancers
remains
unelucidated.
This
study
dealt
with
exploration
expression
pan-cancer
its
significance
regarding
disease
prognosis.
For
this
investigation,
mRNA
data
were
acquired
from
TCGA
GTEx
datasets.
The
Kaplan-Meier
plots,
univariate
Cox
regression,
ROC
curve
employed
for
assessing
prognostic
diagnostic
pan-cancer.
Furthermore,
cBioPortal
database
was
used
analyze
genomic
alterations.
Moreover,
association
infiltration
immune
cells
checkpoint
genes
analyzed
by
TIMER
database.
Gene
Ontology
KEGG
pathway
analysis
explore
function
resulting
demonstrated
that
overexpressed
most
protein
also
high
across
diverse
cancer
types.
upregulated
linked
poor
OS
PFI
certain
cancers.
regression
further
indicated
a
risk
factor
patients
PAAD,
CESC,
LUSC,
LUAD,
CHOL,
LGG,
MESO,
OSCC.
revealed
exhibited
accuracy
(AUC
>
0.9)
BRCA,
ESCA,
GBM,
KIRC
prediction.
pan-cancer,
correlations
cells.
These
findings
collectively
suggest
holds
promise
as
biomarker
purposes
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 4, 2025
Abstract
Uveal
melanoma
(UM)
is
the
most
frequent
primary
intraocular
malignancy
in
adults
with
high
metastasis
and
mortality
rate,
whose
effective
therapeutic
strategy
still
urgent
need.
Specifically,
apoptosis-resistance
a
great
challenge
for
advanced
UM
patients,
therefore
novel
options
targeting
otherwise
death
modality,
which
may
potentially
enhance
treatment
effect,
need
to
be
further
identified.
Here,
by
kinase
inhibitor
library
of
113
approved
drugs
screening,
JTC801,
selective
antagonist
nociceptin
receptor
(NOP),
exhibits
specifically
strong
tumor-killing
ability
lower
dosage.
JTC801
induces
cell
methuosis-like
characterized
cytoplasmic
vacuolization,
markedly
regresses
tumor
progression
metastasis,
prolongs
survival
multiple
models
without
apparent
adverse
effects.
Mechanistically,
JTC801-caused
nutrient-deficient
stress
mitochondrial
damage
triggers
macropinocytosis
vacuolization
cells.
Concomitantly,
trapped
into
macropinosomes
that
fuse
lysosomes,
causing
lysosomal
over-acidification,
de-glycosylation
associated
membrane
protein
1(LAMP1),
inhibiting
cathepsinsmaturation,
exacerbating
permeabilization
(LMP),
eventually
inducing
death.
Collectively,
our
findings
identify
as
potential
valuable
antitumor
drug
especially
apoptosis-resistant
provide
insight
distinct
cytotoxicity
role
treatment.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: March 15, 2025
Epidermal
growth
factor
receptor-tyrosine
kinase
inhibitors
(EGFR-TKIs)
are
remarkably
effective
for
treating
EGFR-mutant
non-small
cell
lung
cancer
(NSCLC).
However,
patients
inevitably
develop
acquired
drug
resistance,
resulting
in
recurrence
or
metastasis.
It
is
important
to
identify
novel
therapeutic
targets
reverse
TKI
resistance.
Bioinformatics
analysis
revealed
that
nicotinamide
N-methyltransferase
(NNMT)
was
upregulated
EGFR-TKI
resistant
cells
and
tissues
via
EGR1-mediated
transcriptional
activation.
High
NNMT
levels
were
correlated
with
poor
prognosis
EGFR-mutated
NSCLC
patients,
which
could
promote
resistance
EGFR-TKIs
vitro
vivo.
Mechanistically,
catalyzed
the
conversion
of
1-methyl
by
depleting
S-adenosyl
methionine
(the
methyl
group
donor),
leading
a
reduction
H3K9
trimethylation
(H3K9me3)
H3K27
(H3K27me3)
subsequent
epigenetic
activation
EGR1
ALDH3A1.
In
addition,
ALDH3A1
increased
lactic
acid
levels,
further
promoted
expression
p300-mediated
histone
H3K18
lactylation
on
its
promoter.
Thus,
mediates
formation
double
positive
feedback
loop
lactate,
EGR1/NNMT/EGR1
NNMT/ALDH3A1/lactate/NNMT.
Moreover,
combination
small-molecule
inhibitor
(NNMTi)
osimertinib
exhibited
promising
potential
treatment
an
osimertinib-resistant
xenograft
model.
The
combined
contribution
these
two
loops
promotes
NSCLC.
Our
findings
provide
new
insight
into
role
methylation
pivotal
NNMT-mediated
may
serve
as
powerful
target
overcoming